RecovryAI provides FDA‑regulated, physician‑prescribed virtual care assistants that engage patients directly after surgery, delivering procedure‑specific, clinically validated recovery guidance. The AI monitors patients’ recovery trajectories and automatically alerts the care team when deviations occur, enabling timely intervention. By functioning as a regulated medical device, the platform bridges the gap between provider‑facing AI tools and consumer health apps, ensuring both safety and accountability.
Funding
Funding not disclosed
Founders
Product
Problem
Patients recovering from surgery often receive limited, generic discharge instructions and lack continuous clinical oversight at home, leading to delayed identification of complications and suboptimal recovery outcomes.
Solution
RecovryAI offers FDA‑regulated, physician‑prescribed Virtual Care Assistants (VCAs) that engage patients directly after discharge. Each VCA provides procedure‑specific, clinically validated step‑by‑step recovery guidance. The AI monitors patient-reported data and symptom trends, automatically flagging deviations from expected recovery patterns. When a deviation is detected, the system escalates the case to a licensed provider for timely intervention, extending clinical oversight into the home environment and supporting safer, smoother recoveries.
Target Audience
Primary customers are surgeons, hospitals, and ambulatory surgical centers that prescribe postoperative care plans and seek to extend monitoring and support to patients after discharge.
Features
- Procedure‑specific virtual assistants built as regulated medical device software
- Real‑time, AI‑driven monitoring of patient-reported symptoms and adherence to recovery protocols
- Automatic escalation alerts to the patient’s care team when recovery deviates from expected trajectories
- Clinician‑prescribed deployment ensuring integration with existing postoperative care plans
- Secure, HIPAA‑compliant data handling and communication between patients and providers